Professor Viktor Grünwald at ESMO 2023 had a lecture on prognostic factors of renal cell carcinoma and in a recent podcast analyzed the importance of side effect profiles of new treatment options in RCC. We asked him, considering all these data and the current guidelines, how he differentiates between various treatments.
Video: https://medicaldigest.org/scientific-contents/interview:medical-treatment-renal-cell-carcinoma-2023
